IF 1 Q4 ONCOLOGY Melanoma Management Pub Date : 2024-12-01 Epub Date: 2024-12-29 DOI:10.1080/20450885.2024.2442874
Muhammad Anas Kudsi, Anas Alsheikh Hamdoun, Osama Haj Osman, Lina Ghabreau, Nour Hakim, Aladdin Etr
{"title":"A rare and challenging case of amelanotic subungual melanoma from Syria.","authors":"Muhammad Anas Kudsi, Anas Alsheikh Hamdoun, Osama Haj Osman, Lina Ghabreau, Nour Hakim, Aladdin Etr","doi":"10.1080/20450885.2024.2442874","DOIUrl":null,"url":null,"abstract":"<p><p>Subungual melanoma accounts for 1.9% of cutaneous melanomas. Amelanotic cases, comprising 15-25%, poses a significant diagnostic challenge because it can be misdiagnosed as other traumatic, inflammatory, or neoplastic conditions. This often leads to delayed diagnosis and subsequently, a poor prognosis. We present a case of an 83-year-old woman with a bleeding, painful and progressive lesion on the nail area of her right middle finger initially misdiagnosed as paronychia at a rural clinic four months ago. An incisional biopsy confirmed the diagnosis of amelanotic subungual melanoma. Amputation of the affected finger was performed successfully. Imaging studies showed no metastatic disease. This case underscores the importance of early recognition and management of subungual melanoma, particularly in remote rural areas, to optimize patient outcomes.</p>","PeriodicalId":44562,"journal":{"name":"Melanoma Management","volume":"11 1","pages":"2442874"},"PeriodicalIF":1.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703459/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melanoma Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20450885.2024.2442874","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

舌下黑色素瘤占皮肤黑色素瘤的 1.9%。黑色素瘤病例占 15%-25%,由于可能被误诊为其他创伤性、炎症性或肿瘤性疾病,因此给诊断带来了巨大挑战。这往往会导致诊断延迟,进而导致预后不良。我们介绍了一例 83 岁妇女的病例,她的右手中指指甲部位有出血、疼痛和进行性病变,四个月前在一家乡村诊所就诊时最初被误诊为甲沟炎。切开活检确诊为绒毛膜下黑色素瘤。患指截肢手术顺利完成。影像学检查显示没有转移性疾病。本病例强调了早期识别和治疗舌下黑色素瘤的重要性,尤其是在偏远的农村地区,以优化患者的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A rare and challenging case of amelanotic subungual melanoma from Syria.

Subungual melanoma accounts for 1.9% of cutaneous melanomas. Amelanotic cases, comprising 15-25%, poses a significant diagnostic challenge because it can be misdiagnosed as other traumatic, inflammatory, or neoplastic conditions. This often leads to delayed diagnosis and subsequently, a poor prognosis. We present a case of an 83-year-old woman with a bleeding, painful and progressive lesion on the nail area of her right middle finger initially misdiagnosed as paronychia at a rural clinic four months ago. An incisional biopsy confirmed the diagnosis of amelanotic subungual melanoma. Amputation of the affected finger was performed successfully. Imaging studies showed no metastatic disease. This case underscores the importance of early recognition and management of subungual melanoma, particularly in remote rural areas, to optimize patient outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.10
自引率
0.00%
发文量
4
审稿时长
13 weeks
期刊介绍: Skin cancer is on the rise. According to the World Health Organization, 132,000 melanoma skin cancers occur globally each year. While early-stage melanoma is usually relatively easy to treat, once disease spreads prognosis worsens considerably. Therefore, research into combating advanced-stage melanoma is a high priority. New and emerging therapies, such as monoclonal antibodies, B-RAF and KIT inhibitors, antiangiogenic agents and novel chemotherapy approaches hold promise for prolonging survival, but the search for a cure is ongoing. Melanoma Management publishes high-quality peer-reviewed articles on all aspects of melanoma, from prevention to diagnosis and from treatment of early-stage disease to late-stage melanoma and metastasis. The journal presents the latest research findings in melanoma research and treatment, together with authoritative reviews, cutting-edge editorials and perspectives that highlight hot topics and controversy in the field. Independent drug evaluations assess newly approved medications and their role in clinical practice. Key topics covered include: Risk factors, prevention and sun safety education Diagnosis, staging and grading Surgical excision of melanoma lesions Sentinel lymph node biopsy Biological therapies, including immunotherapy and vaccination Novel chemotherapy options Treatment of metastasis Prevention of recurrence Patient care and quality of life.
期刊最新文献
BRAF-mutant melanoma management: a single center retrospective analysis of patients treated with sequential therapy. Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review. Melanoma in a Colombian population: a survival study. A rare and challenging case of amelanotic subungual melanoma from Syria. Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1